Results 241 to 250 of about 69,822 (254)

3D-printed construct from hybrid suspension as spatially and temporally controlled protein delivery system

Journal of Biomaterials Applications, 2021
Jiangtao Wang, Baojun Xie, Zicai Zhu
exaly  

Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology

European Journal of Pharmaceutics and Biopharmaceutics, 2021
David Cipolla
exaly  

12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD

Pneumologie, 2019
G.T. Ferguson, K.F. Rabe, E. Bourne, S. Ballal, K. DeAngelis, M. Aurivillius, C. Reisner, P. Dorinsky   +7 more
openaire   +1 more source

Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension

Drug Delivery and Translational Research, 2022
Estelle-Vionè Louw, Wilna Liebenberg, Clarissa Willers   +2 more
exaly  

Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology

European Journal of Pharmaceutical Sciences, 2018
Glyn Taylor, Chad Orevillo, Andrea Maes   +2 more
exaly  

Novel hydrofluoroalkane suspension formulations for respiratory drug delivery

Expert Opinion on Drug Delivery, 2005
Philippe Rogueda
exaly  

Intracellular Photothermal Delivery for Suspension Cells Using Sharp Nanoscale Tips in Microwells

ACS Nano, 2019
Tianxing Man, Xiongfeng Zhu, Yu Ting Chow   +2 more
exaly  

A Cumulative Dose (1440 µg) Study to Evaluate the Efficacy, PK, Extrapulmonary PD, and Safety of Albuterol Sulfate MDI in Co-Suspension Delivery Technology (AS MDI; PT007) in Patients with Asthma

A31. ASTHMA: CLINICAL STUDIES I, 2019
A. Maes, C. Cappelletti, K. Rossman, M. Gillen, C.F. LaForce, C. Reisner   +5 more
openaire   +1 more source

Bone Mineral Density and Ocular Safety After 52 Weeks' Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Using Co-Suspension Delivery Technology in COPD

B45. COPD: TREATMENT, 2019
E.M. Kerwin, G.T. Ferguson, M. Mo, K. DeAngelis, P. Dorinsky   +4 more
openaire   +1 more source

Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study

Pneumologie, 2019
Fernando Martinez, Gary Ferguson, Eric Bourne, Shaila Ballal, Patrick Darken, Kiernan DeAngelis, Magnus Aurivillius, Paul Dorinsky, Colin Reisner   +8 more
openaire   +1 more source